logo-loader
AIM:LLAI

LungLife AI Inc

Receive alerts
Market:
AIM
Price
-
Day Change
-
Market Cap:
-
52 weeks high
-
52 weeks low
-

In brief

LungLife AI Inc is a developer of clinical diagnostic solutions for lung cancer enhanced by AI. The company’s technology is comprised of rare-cell enrichment combined with blood-based biomarkers shown to be altered in lung cancer.

The company employs machine learning to identify informative cells from blood and intends to build a deep, novel pool of lung cancer-related data for AI-enabled applications designed to improve test performance over time.